One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals Post author: Post published:November 16, 2023 Post category:uncategorized The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients. You Might Also Like How does prenatal cannabis use affect neonatal outcomes? June 23, 2024 New weight loss drug may be an effective strategy for preventing or treating high blood pressure February 5, 2024 Unveiling the role of auto-antibodies in COVID-19 severity June 19, 2024
New weight loss drug may be an effective strategy for preventing or treating high blood pressure February 5, 2024